Quest Diagnostics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$776.75 | $636.99 | 12.97% | 9 | $699.39B |
| NOVN | Novartis | Hold |
10
|
CHF89.05 | CHF105.00 | 20.85% | 9 | CHF181.70B |
| ROG | Roche Holding | Hold |
16
|
CHF220.60 | CHF307.83 | 23.53% | 9 | CHF178.03B |
| ABT | Abbott Laboratories | Outperform |
9
|
$106.29 | $118.92 | 19.01% | 7 | $184.43B |
| DHR | Danaher | Outperform |
10
|
$246.89 | $260.33 | 9.77% | 4 | $182.87B |
| PFE | Pfizer | Outperform |
2
|
$27.18 | $32.87 | 12.21% | 6 | $153.91B |
| GSK | GSK | Outperform |
12
|
£17.05 | £17.30 | 14.37% | 12 | £69.53B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$233.72 | $284.47 | 18.73% | 8 | $67.52B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.34k | ¥5.24k | 8.72% | 0 | ¥10.23T |
| IQV | IQVIA Holdings | Outperform |
15
|
$232.94 | $267.27 | 18.06% | 19 | $42.40B |
| BAYN | Bayer | Hold |
5
|
27.35€ | 45.15€ | 9.69% | 4 | 26.87€B |
| ICLR | ICON Public | Buy |
16
|
$301.61 | $306.07 | 19.36% | 1 | $24.94B |
| 7751 | Canon | Hold |
18
|
¥4.28k | ¥3.74k | -11.24% | 0 | ¥3.69T |
| ILMN | Illumina | Outperform |
16
|
$124.68 | $159.28 | 20.31% | 9 | $19.86B |
| HOLX | Hologic | Outperform |
8
|
$76.28 | $81.06 | 10.12% | 3 | $17.91B |
| LH | Laboratory Corp of America Hol... | Outperform |
11
|
$201.32 | $241.28 | 19.71% | 9 | $16.97B |
| BVI | Bureau Veritas | Outperform |
18
|
27.42€ | 26.96€ | 13.06% | 12 | 12.44€B |
| BIM | bioMérieux | Outperform |
18
|
100.00€ | 105.55€ | 14.00% | 1 | 11.82€B |
| 4523 | Eisai | Outperform |
18
|
¥6.55k | ¥9.58k | 28.26% | 0 | ¥1.86T |
| ERF | Eurofins Scientific | Hold |
18
|
57.60€ | 0.00€ | 4.17% | 5 | 11.11€B |
| CRL | Charles River Laboratories Int... | Outperform |
16
|
$232.69 | $229.97 | 18.94% | 11 | $11.76B |
| NTRA | Natera | Outperform |
7
|
$94.15 | $74.41 | 9.40% | 8 | $11.35B |
| BRKR | Bruker | Outperform |
16
|
$79.03 | $73.64 | 14.51% | 1 | $11.34B |
| EXAS | Exact Sciences | Buy |
8
|
$60.01 | $90.32 | 47.66% | 7 | $10.91B |
| APOLLOHOSP | Apollo Hospitals Enterprise | Outperform |
18
|
Rp5.95k | Rp6.91k | 18.55% | 17 | Rp855.10B |
| CTLT | Catalent | Hold |
15
|
$56.00 | $49.29 | 13.39% | 3 | $10.11B |
| ITRK | Intertek Group | Outperform |
18
|
£48.90 | £44.87 | 7.98% | 14 | £7.97B |
| 543220 | Max Healthcare Institute | Outperform |
12
|
Rp839.20 | Rp644.73 | 4.86% | 9 | Rp815.63B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$42.81 | $0.00 | 16.80% | 3 | $9.39B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$274.06 | $536.80 | 55.70% | 1 | $7.74B |
| TXG | 10x Genomics | Outperform |
6
|
$26.92 | $58.14 | 50.45% | 2 | $3.51B |
| EVH | Evolent Health | Buy |
9
|
$27.27 | $44.92 | 63.18% | 5 | $3.18B |
| QDEL | Quidel Corp | Hold |
16
|
$39.68 | $121.00 | 34.07% | 6 | $2.71B |
| PINC | Premier | Hold |
16
|
$21.06 | $24.14 | 13.96% | 1 | $2.50B |
| LALPATHLAB | Dr. Lal PathLabs | Hold |
18
|
Rp2.37k | Rp2.35k | 5.69% | 1 | Rp197.03B |
| GH | Guardant Health | Buy |
6
|
$18.26 | $43.00 | 140.96% | 2 | $2.19B |
| 300676 | BGI Genomics | - |
17
|
¥41.13 | ¥0.00 | -100.00% | 0 | ¥15.61B |
| EVT | Evotec | Outperform |
14
|
9.74€ | 37.33€ | 161.81% | 4 | 1.73€B |
| SDGR | Schrödinger | Outperform |
6
|
$25.26 | $44.22 | 48.46% | 1 | $1.84B |
| NEO | NeoGenomics | Outperform |
8
|
$13.96 | $20.09 | 36.10% | 9 | $1.78B |
| MYGN | Myriad Genetics | Hold |
6
|
$19.47 | $22.08 | 28.40% | 8 | $1.77B |
| APPS | Applus Services | Outperform |
15
|
12.68€ | 10.92€ | -9.70% | 3 | 1.63€B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
| METROPOLIS | Metropolis Healthcare | Hold |
16
|
Rp1.82k | Rp1.56k | -1.42% | 10 | Rp93.12B |
| 000710 | Berry Genomics Co.,Ltd | - |
10
|
¥7.23 | ¥56.76 | -100.00% | 0 | ¥5.09B |
| FLGT | Fulgent Genetics | Hold |
16
|
$20.70 | $31.50 | 20.77% | 2 | $608.48M |
| CEVI | CellaVision AB (publ) | Outperform |
16
|
kr225.50 | kr191.75 | 8.65% | 3 | kr5.38B |
| OSUR | OraSure Technologies | Hold |
11
|
$5.33 | $7.40 | 36.02% | 4 | $404.74M |
| CDNA | CareDx, Inc | Outperform |
9
|
$9.18 | $11.80 | 41.61% | 1 | $403.58M |
| ADPT | Adaptive Biotechnologies | Outperform |
6
|
$2.79 | $8.67 | 115.05% | 2 | $386.11M |
| HCAT | Health Catalyst | Outperform |
7
|
$6.31 | $11.92 | 82.25% | 12 | $367.19M |
| ATOS | Atossa Genetics Inc | Buy |
5
|
$1.53 | $4.83 | 161.44% | 0 | $219.28M |
| CRDF | Cardiff Oncology | Buy |
10
|
$4.23 | $8.37 | 105.20% | 1 | $200.30M |
| GLAXO | GlaxoSmithKline Pakistan | - |
18
|
₨79.00 | ₨0.00 | -100.00% | 0 | ₨37.46B |
| CPSI | Computer Programs and Systems | Outperform |
18
|
$8.06 | $16.50 | 48.88% | 2 | $118.34M |
| PRPH | ProPhase Labs |
13
|
$5.19 | $15.50 | 304.62% | 2 | $89.50M | |
| NYMX.F | Nymox Pharmaceutical | - |
9
|
$0.47 | $0.00 | -100.00% | 0 | $86.74M |
| IMMNOV | Immunovia AB (publ) | - |
0
|
kr1.94 | kr0.00 | -100.00% | 0 | kr747.75M |
| HEALTH | Nightingale Health Oyj | Outperform |
2
|
1.79€ | 1.10€ | -30.17% | 1 | 61.31€M |
| CCEL | Cryo-Cell International | Outperform |
14
|
$8.29 | $10.00 | 8.56% | 0 | $64.19M |
| ENZ | Enzo Biochem | - |
8
|
$1.36 | $5.50 | -100.00% | 0 | $62.10M |
| RENX | Renalytix Plc | Buy |
4
|
£0.24 | £1.79 | -100.00% | 0 | £37.87M |
| CODX | Co-Diagnostics | Hold |
10
|
$1.19 | $3.00 | 110.08% | 1 | $35.47M |
| XGN | Exagen | Buy |
6
|
$1.36 | $5.75 | 267.65% | 2 | $23.61M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$0.94 | $5.00 | -100.00% | 1 | $21.49M |
| PMD | Psychemedics | - |
0
|
$3.10 | $32.00 | -100.00% | 0 | $12.07M |
| LXXG.Q | LexaGene Holdings | - |
4
|
$0.11 | $0.75 | -100.00% | 0 | $11.34M |
| APDN | Applied DNA Sciences | Outperform |
10
|
$4.03 | $2.50 | 1016.63% | 0 | $10.29M |
| NSTG | NanoString Technologies | - |
7
|
$0.19 | $5.02 | -100.00% | 4 | $9.62M |
| PRPO | Precipio | - |
0
|
$5.62 | $19.00 | -100.00% | 1 | $9.44M |
| OPGN | OpGen |
2
|
$0.41 | $3.00 | -100.00% | 1 | $4.61M | |
| IDXG | Interpace Biosciences | - |
0
|
$1.06 | $11.00 | -100.00% | 0 | $4.54M |
| RKDA | Arcadia Biosciences | Buy |
8
|
$2.54 | $15.00 | 333.07% | 0 | $3.18M |
| NVTA | Invitae | - |
4
|
$0.00 | $0.71 | 0.00% | 8 | $3.18M |
| BIOC.Q | Biocept | Hold |
-16
|
$0.00 | $8.00 | 0.00% | 0 | $0.13M |
| ROSG.Q | Rosetta Genomics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| MTST | MetaStat | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| RGDX.Q | Response Genetics, Inc | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |